・Analysts estimate about 116% upside for REPL, compared to a 124% upside for IOVA from current levels. ・Amtagvi, already approved for melanoma, helped Iovance generate about $264 million in product ...

The 9.1-CVSS vulnerability enables attackers to circumvent RCE protections in the de facto template engine for the Java ...

The federal government's disease-tracking agency has paused its diagnostic testing for rabies, monkeypox, and a number of other infectious diseases. The CDC this week posted a list of more than two ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. President Donald Trump once joked that his supporters would get sick of ...

The NFL, in collaboration with the NFLPA, through their respective appointed biomechanical experts, coordinated extensive laboratory research to evaluate which helmets best reduce head impact ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Anthropic said on Tuesday that it has halted the broader release of its newest AI model, Mythos, due ...

When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...